- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 5.09M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.26M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.67M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.77M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.05M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.55M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $12.04M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $12.64M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 4.35M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$5.77M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $1.07M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $4.79M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $14.56M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $19.25M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$1.34 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$1.34 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.46M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.45M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$5.82M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$5.9M |